Form D · Biotechnology

AMBERSTONE BIOSCIENCES, INC.

Laguna Hills, CA · CIK 0001896218

Offering snapshot reported Dec 20, 2021 · SEC filing

Reported sold
$6M
Offering amount: $12M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 9, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3M$6MDec 17, 2021: $6,000,000.00Dec 17, 2021Dec 20, 2021: $6,000,000.00Dec 20, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 20, 2021Amendment$6,000,000$0vs Dec 17, 20216SEC filing
Dec 17, 2021Initial$6,000,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-425686

Source: Form D, filed Dec 20, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yonglei Shang Director, Executive
George Guikai Wu Director, Executive
Weian Zhao Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
23181 Verdugo Dr Suite 106
Laguna Hills, CA, 92653